Clinical Trials Update: Sept. 30, 2002
September 30, 2002 04:08:57 PM PST, HealthScout News
Â*
Here are the latest clinical trials, courtesy of CenterWatch.

Chronic Pain

A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Purpose of the study is to understand the effects of intrathecal ziconotide (an experimental pain medication) when the dose is slowly increased over a 3-week period. Sites throughout the USA.

More Information
Please see http://www.centerwatch.com/patient/studies/cat45.html.
-----
Drugs Newly Approved by the FDA

Hepsera (adefovir dipivoxil)

For the treatment of chronic hepatitis B in adults with evidence of active viral replication; Gilead Sciences; Approved September 2002.
More Information
Please see http://www.centerwatch.com/patient/drugs/dru797.html.
-----
Fluzone Preservative-free

Preservative free, pediatric dose, influenza virus vaccine for the immunization of infants; Aventis Pasteur; Approved September 2002.
More Information
http://www.centerwatch.com/patient/drugs/dru798.html.
-----
Copyright @#169;2002 Centerwatch. All rights reserved.